Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Acquisitions (2016 - 2025)

Phibro Animal Health has reported Acquisitions over the past 8 years, most recently at -$5.3 million for Q2 2025.

  • Quarterly results put Acquisitions at -$5.3 million for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was -$4.3 million (down 261.88% YoY), and the annual figure for FY2025 was $286.5 million, up 8630.32%.
  • Acquisitions for Q2 2025 was -$5.3 million at Phibro Animal Health, down from $1.1 million in the prior quarter.
  • Over the last five years, Acquisitions for PAHC hit a ceiling of $2.7 million in Q2 2022 and a floor of -$5.3 million in Q2 2025.
  • Median Acquisitions over the past 3 years was $504500.0 (2024), compared with a mean of -$403750.0.
  • Peak annual rise in Acquisitions hit 2493.18% in 2025, while the deepest fall reached 2493.18% in 2025.
  • Phibro Animal Health's Acquisitions stood at $2.7 million in 2022, then crashed by 101.61% to -$44000.0 in 2024, then crashed by 12056.82% to -$5.3 million in 2025.
  • The last three reported values for Acquisitions were -$5.3 million (Q2 2025), $1.1 million (Q1 2025), and -$44000.0 (Q1 2024) per Business Quant data.